G
Glenn M. Chertow
Researcher at Stanford University
Publications - 830
Citations - 94517
Glenn M. Chertow is an academic researcher from Stanford University. The author has contributed to research in topics: Kidney disease & Dialysis. The author has an hindex of 128, co-authored 764 publications receiving 82401 citations. Previous affiliations of Glenn M. Chertow include University of Groningen & Fresenius Medical Care.
Papers
More filters
Journal ArticleDOI
Chronic Inflammation in Chronic Kidney Disease Progression: Role of Nrf2.
Peter Stenvinkel,Glenn M. Chertow,Prasad Devarajan,Adeera Levin,Sharon P. Andreoli,Sripal Bangalore,Bradley A. Warady +6 more
TL;DR: This review aims to clarify the mechanisms of chronic inflammation in the pathophysiology and disease progression across the spectrum of kidney diseases, with a focus on Nrf2.
Journal ArticleDOI
Phosphorus balance and mineral metabolism with 3 h daily hemodialysis
Juan Carlos Ayus,Steven G. Achinger,M. R. Mizani,Glenn M. Chertow,Wieslaw B Furmaga,S. Lee,F. Rodriguez +6 more
TL;DR: DHD improves phosphorus control by increasing dialytic phosphorus removal while maintaining nutritional status and reducing the use of phosphate binders, the net effect allows for improved achievement of mineral metabolism goals.
Journal ArticleDOI
Effect of Tenapanor on Serum Phosphate in Patients Receiving Hemodialysis
Geoffrey A. Block,David P. Rosenbaum,Maria Leonsson-Zachrisson,Magnus Åstrand,Susanne Johansson,Mikael Knutsson,Anna Maria Langkilde,Glenn M. Chertow +7 more
TL;DR: Tenapanor treatment resulted in statistically significant, dose-dependent reductions in serum phosphate concentrations in patients with hyperphosphatemia receiving hemodialysis, and diarrhea was the most common adverse event.
Journal ArticleDOI
Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease.
John W. Stanifer,Sean D. Pokorney,Glenn M. Chertow,Stefan H. Hohnloser,Daniel Wojdyla,Samira Garonzik,Wonkyung Byon,Ziad Hijazi,Renato D. Lopes,John H. Alexander,Lars Wallentin,Christopher B. Granger +11 more
TL;DR: Substantial overlap is observed in the range of exposure to apixaban 5 mg twice daily for patients with or without advanced chronic kidney disease, supporting conventional dosing in patients with CrCl 25 to 30 mL/min.
Journal ArticleDOI
The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial
Patrick S. Parfrey,Tilman B. Drüeke,Geoffrey A. Block,Ricardo Correa-Rotter,Jürgen Floege,Charles A. Herzog,Gérard M. London,Kenneth W. Mahaffey,Sharon M. Moe,David C. Wheeler,Yumi Kubo,Bastian Dehmel,William G. Goodman,Glenn M. Chertow,J. Santos,C. Najun Zarazaga,I. Marin,N. Garrote,Ana María Cusumano,N. Peñalba,E. Del Valle,Luis A. Juncos,J. Martinez Saye,L. Lef,V. Altobelli,G. Petraglia,G. Rosa Diez,Walter Douthat,J. Lobo,C. Gallart,A. Lafalla,G. Diez,B. Linares,Nicole Lopez,N. Ramirez,R. Gonzalez,R. Valtuille,H. Beresan,O. Hermida,G. Rudolf,N. Marchetta,M. Rano,M. Ramirez,N. García,Alastair Gillies,Bernard Jones,Eugenie Pedagogos,Robert J. Walker,G. Talaulikar,Kym M. Bannister,Michael Suranyi,A. Kark,Simon D. Roger,Peter G. Kerr,Alex P.S. Disney,Peter F Mount,M. Fraenkel,M. Mathew,Robert G. Fassett,M. Jose,Carmel M. Hawley,M. Lonergan,J. Mackie,Patrizia Ferrari,S. Menahem,J. Sabto,Brian Hutchison,Robyn G Langham,Carol A. Pollock,H. Holzer,Rainer Oberbauer,I. Arias,H. Graf,Gert Mayer,K. Lhotta,U. Neyer,R. Klauser,W. Hoerl,S. Horn,J. Kovarik,Reinhard Kramar,M. Eigner,Michel Dhaene,J. Billiouw,J. De Meester,Xavier Warling,P. Cambier-Dwelschauwers,Pieter Evenepoel,R. Daelemans,Max Dratwa,Brigitte Maes,Stolear Jc,Tom Dejagere,J Vanwalleghem,K. Bouman,Michel Jadoul,J Peeters,Raymond Vanholder,C. Tielemans,J. Donck,F. Almeida,J. Picollo de Oliveira,Emmanuel A. Burdmann,V. Garcia,F. Saldanha Thome,L. Deboni,R. Bregman,Jocemir Ronaldo Lugon,Sônia M. H. A. Araújo,S. Ferreira Filho,E. de Francesco Daher,M. Sperto Baptista,Antonio Carlos Carvalho,Domingos O. d'Avila,M. Moyses Neto,L. Yu,M. Bastos,P. Sampaio Lacativa,Vanda Jorgetti,E. de Almeida Romão,J. Cardeal da Costa,R. Pecoits Filho,Pedro Alejandro Gordan,N. Salgado,M. Teixeira Araújo,S. Neiva Coelho,Ilka Regina Souza de Oliveira,Rosa M.A. Moysés,L. Vasconcellos,P. Batista,J. Luiz Gross,A. Pedrosa,S. Cournoyer,Martine Leblanc,S. Chow,S. Karunakaran,G. Wong,S. Tobe,S. Desmeules,Deborah Zimmerman,Shannon Murphy,P. Montambault,Seamas C. Donnelly,Jennifer M. MacRae,Bruce F. Culleton,Steven D. Soroka,Christian Rabbat,Kailash Jindal,M. Vasilevsky,M. Michaud,E. Wijeyesinghe,J. Zacharias,C. Lok,N. Muirhead,M. Verrelli,G. Da Roza,D. Sapir,K. Olgaard,H. Daugaard,L. Brandi,P. Jensen,H. Boulechfar,K. Ang,P. Simon,Philippe Rieu,P. Brunet,G. Touchard,G. London,P. Urena Torres,C. Combe,A. Durrbach,J. Ortiz,T. Hannedouche,C. Vela,A. Lionet,P. Ryckelynck,P. Zaoui,G. Choukroun,H. Fessi,P. Lang,P. Stroumza,D. Joly,C. Mousson,Maurice Laville,F. Dellanna,C. Erley,Johann Braun,M. Rambausek,W. Riegel,M. Klingberg,E. Schwertfeger,V. Wizemann,K.-U. Eckardt,H. Reichel,J. Floege,J. Passauer,E. Hübel,N. Frischmuth,R. Liebl,R. Fiedler,V. Schwenger,A. Voßkühler,U. Kunzendorf,L. Renders,D. Rattensberger,Lars Christian Rump,Markus Ketteler,H. Neumayer,F. Zantvoort,R. Stahl,E. Ladanyi,I. Kulcsar,I. Mezei,Botond Csiky,C. Rikker,O. Arkossy,K. Berta,J. Szegedi,L. Major,S. Ferenczi,A. Fekete,T. Szabo,G. Zakar,Galen S. Wagner,S. Kazup Erdelyine,B. Borbas,Joseph A. Eustace,D. Reddan,Giovambattista Capasso,Francesco Locatelli,Giuseppe Villa,Mario Cozzolino,Diego Brancaccio,Piergiorgio Messa,Piergiorgio Bolasco,Biagio Ricciardi,Fabio Malberti,E. Moriero,Giuseppe Cannella,V. Ortalda,Sergio Stefoni,G. Frascà,Gianni Cappelli,Alberto Albertazzi,Carmine Zoccali,M. Farina,A. Elli,Ferdinando Avella,Patrizia Ondei,G. Mingardi,R. Errico,A. Losito,S. Di Giulio,Giovanni Pertosa,F. Schena,G. Grandaliano,Loreto Gesualdo,M. Auricchio,T. Bochicchio-Ricardelli,Ricardo Correa-Rotter,F. Aranda Verástegui,J. Peña,A. Chew Wong,J. Cruz-Valdez,M. Torres Zamora,M. Solis,M. Sebastian Diaz,M. Vital Flores,E. Alvarez Sandoval,M.A. van den Dorpel,HS Brink,W. Van Kuijk,C. Vermeij,P. Smak Gregoor,E. Hagen,F. van der Sande,Marian Klinger,M. Nowicki,M. Muszytowski,K. Bidas,W. Bentkowski,Andrzej Wiecek,A. Ksiazek,K. Marczewski,M. Ostrowski,M. Switalski,W. Sulowicz,Joanna Matuszkiewicz-Rowińska,M. Mysliwiec,M. Durlik,B. Rutkowski,F. Macario,B. Carvalho,João M. Frazão,D. Machado,A. Weigert,A. Andrusev,O. Khrustalev,A. Zemtchenkov,K. Gurevich,K. Staroselsky,N. Khadikova,Liudmila Rozhinskaya,G. Timokhovskaya,A. Strokov,O. Balkarova,V. Ermolenko,E. Kolmakova,M. Komandenko,M. Timofeev,V. Shilo,G. Shostka,A. Smirnov,V. Anashkin,G. Volgina,O. Domashenko,Andrey Gurevich,D. Perlin,J. Martínez García,E. Andrés Ribes,E. Coll Piera,M. Fernandez Lucas,M. Galicia,M. Prados,Myriam González,R. Romero,de Francisco Martín de Francisco,J. Montenegro,C. Santiago,F. García,J. Alcázar de La Ossa,J. Arrieta,J. Pons,Alejandro Martin-Malo,J. Soler Amigó,Aleix Cases,G. Sterner,G. Jensen,B. Wikström,S. Jacobson,U. Lund,L. Weiss,A. Ståhl,B. von Albertini,Michel Burnier,P. Meier,Paul J. Martin,D. Uehlinger,M. Dickenmann,Muhammad M. Yaqoob,Daniel Zehnder,Philip A. Kalra,D. Wheeler,N. Padmanabhan,S. Roe,D. Eadington,N. Pritchard,Alastair J. Hutchison,Simon J. Davies,Martin Wilkie,Matthew R. P. Davies,P. Pai,P. Swift,J. Kwan,David Goldsmith,Charles R.V. Tomson,J. Stratton,I. Dasgupta,S. Sarkar,Moustafa Moustafa,K. Gandhi,A. Jamal,E. Galindo-Ramos,Jennifer Tuazon,Daniel Batlle,K. Tucker,B. Schiller-Moran,A. Assefi,C. Martinez,L. Samuels,J. Goldman,J. Cangiano-Rivera,R. Darwish,M. Lee,J. Topf,K. Kapatkin,H. Baer,R. Kopelman,Muralidhar Acharya,D. Tharpe,M. Bernardo,P. Nader,J. Guzman-Rivera,Pablo E. Pergola,M. Sekkarie,E. Alas,Philip G Zager,K. Liss,Jesus Navarro,Michael Roppolo,C. Denu-Ciocca,A. Kshirsagar,M. El Khatib,Kant Ks,D. Scott,B. Murthyr,Fredric O. Finkelstein,G. Keightley,R. McCrary,J. Pitone,T. Cavalieri,A. Tsang,B. Pellegrino,R. Schmidt,S. Ahmad,Cynthia J. Brown,E. Friedman,N. Mittman,Stephen Z. Fadem,W. Shapiro,M. Reddy,S. Goldberger,Y. Woredekal,A. Agarwal,Michael Anger,M. Haque,P. Chidester,R. Kohli,S. Rubinstein,G. Newman,R. Gladish,O. Ayodeji,S. Soman,Stuart M. Sprague,N. Hunt,T. Gehr,Dana V. Rizk,David G. Warnock,D. Polack,Madeleine V. Pahl,Dagmar-C. Fischer,P. Dreyer,G. James,Fred E. Husserl,T. Rogers,A. Raff,John R. Sedor,Marcia R. Silver,Maree-Ross Smith,S. Steinberg,T. DelGiorno,E.M. Jones,P. D. Cunha,J. Cheng,V. Pogue,Geoffrey A. Block,Samuel S. Blumenthal,Elizabeth E. Brown,Chaim Charytan,J. Buerkert,M. Cook,A. Felsenfeld,N. Tareen,Arun Gupta,T. Herman,S. Diamond,C. Hura,M. Laski,J. MacLaurin,T. Plumb,G. Brosnahan,J. Kumar,M. Henriquez,C. Poole,E. Osanloo,A. Matalon,C. Sholer,S. Arfeen,M. Azer,M. Belledonne,M. Gross,E. Dunnigan,K. McConnell,Bryan N. Becker,F. Skinner,R. Rigolosi,David Spiegel,M. Stegman,R. Patak,D. Streja,U. Ranjit,T. Youell,T. Wooldridge,C. Stafford,R. Cottiero,M. Weinberg,M. Schonefeld,E. Shahmir,A. Hazzan,Akhtar Ashfaq,K. Bhandari,W. Cleveland,M. Culpepper,J. Golden,L. Lai,Y. Lien,V. Lorica,J. Robertson,K. Malireddi,S. Morse,V. Thakur,A. Israelit,P. Raguram,H. Alfred,W. Weise,F. Al-Saghir,M. El Shahawy,Anjay Rastogi,Allen R. Nissenson,Nelson Kopyt,Robert I. Lynn,Janice P. Lea,William M. McClellan,P. Teredesai,S. Ong,S. Tolkan,Jared G. Sugihara,T. Minga,Rajnish Mehrotra,R. Minasian,D. Bhatia,R. Specter,J. Capelli,P. Sidhu,Sanjay Dalal,P. Dykes,M. Khan,F. Rahim,M. Saklayen,Alison Thomas,Beckie Michael,M. D. Torres,H. Al-Bander,B. Murray,A. Abukurah,B. Gupta,S. Nosrati,R. Raja,Steven Zeig,Michael C. Braun,A. Amatya,J. Endsley,Z. Sharon,G. Dolson,F. Dumler,K. Ntoso,Steven J. Rosansky,N. Kumar,V. Gura,N. Thompson,David S. Goldfarb,R. Halligan,John P. Middleton,A. Widerhorn,L. Arbeit,Jose A.L. Arruda,T. Crouch,L. Friedman,S. Khokhar,J. Mittleman,P. Light,B. Taparia,C. West,J. Cotton,R. Dhingra,L. Kleinman,F. Arif,S. Lew,T. Nammour,J. Sterrett,Margaret M. Williams,J. Ramirez,J. Rubin,James T. McCarthy,S. Noble,M. Chaffin,A. Rekhi +586 more
TL;DR: In the EVOLVE trial as mentioned in this paper, a global, multicenter, randomized placebo-controlled trial in 3883 prevalent patients on hemodialysis, whose outcomes included death, major CV events, and development of severe unremitting secondary hyperparathyroidism (HPT).